Valued at USD 6.02 billion in 2024, the vascular access device market is projected to reach USD 6.49 billion in 2025 and USD 13.65 billion by 2034, growing at a CAGR of 7.7% during the forecast period 2025–2034. North America was the largest regional market in 2024. Growth is underpinned by an aging global population, rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders, and increasing adoption of minimally invasive procedures. Key players include B. Braun Melsungen AG, C.R. Bard (acquired by Medtronic), Cook Medical, Terumo Corporation, Smiths Medical, Medtronic, Abbott Laboratories, Teleflex Incorporated, AngioDynamics, Fresenius Medical Care, Johnson & Johnson, ICU Medical, Vygon SA, ConvaTec Group, and Becton, Dickinson and Company.

Product Segmentation Shows a Shift Toward Long-Term Access

The vascular access device (VAD) market by product spans short PIVCs, Huber needles, midline catheters, PICCs, CVCs, dialysis catheters, and implantable ports. Short PIVCs hold the largest share given routine intravenous access in hospitals, ease of use, affordability, and minimal complications. In growth terms, peripherally inserted central catheters are registering the highest increase in demand, driven by suitability for long-term intravenous therapy in patients with chronic diseases or cancer. They are increasingly adopted in hospital and home healthcare settings because of reduced complication rates compared with traditional central venous catheters, which maintain a stable presence alongside midline catheters.

Oncology and Nephrology Support Specialized Devices

Huber needles, designed for use with implantable ports, are in demand for long-term therapies, especially for cancer patients requiring frequent medication infusions. The implantable ports segment is also expanding because these devices offer long-term access with minimal discomfort. Dialysis catheters show steady growth, driven by the increasing prevalence of kidney disease and the rising number of patients undergoing dialysis treatments. Together, these segments reflect a preference for less invasive and longer-lasting solutions.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/vascular-access-device-market

Home Healthcare Reshapes Demand

Patients are opting for treatment at home rather than in hospitals, motivated by convenience, reduced healthcare costs, and a more comfortable environment for long-term care. VADs used for chemotherapy, parenteral nutrition, and intravenous medications are increasingly utilized in home settings. According to the Centers for Disease Control and Prevention (CDC), over 40% of home health patients require intravenous therapies. Healthcare providers are seeking ways to manage chronic diseases outside traditional hospital settings, and this trend is expected to grow further.

Regional Insights

North America holds the largest share, supported by advanced healthcare infrastructure, high adoption of medical technologies, a well-established network of hospitals, ambulatory surgery centers, and home healthcare services, high healthcare spending, favorable reimbursement policies, and a growing aging population in the US and Canada. Europe holds a significant share, driven by an aging population and strong healthcare infrastructure in Germany, the UK, and France, though its growth rate is relatively stable. Asia Pacific is expected to experience the highest growth, fueled by improving healthcare access, rising disposable incomes, and chronic disease prevalence in China, India, and Japan, where demand for PICCs and dialysis catheters is rising.

Competitive Landscape

Medtronic expanded its vascular access offerings through the 2017 purchase of C.R. Bard, while B. Braun Melsungen AG offers PICCs, implantable ports, and CVCs with a focus on patient safety and antimicrobial solutions. Market participants are pursuing geographic expansion into Asia Pacific and Latin America, portfolio growth through acquisitions and partnerships, and products tailored to home healthcare. A key restraint is that VADs may cause serious complications such as catheter malposition, cardiac perforation, and extravasation.

Strategic Outlook

With the market expanding at a CAGR of 7.7%, manufacturers that prioritize safety, minimally invasive design, and long-term access vascular access devices , including peripherally inserted central catheters and implantable ports, are well placed to serve oncology, nephrology, and home care demand.

More Trending Latest Reports By Polaris Market Research:

top-5-companies-driving-change-in-carbon-nanotube-market-in-2025

medical-devices-market-outlook-healthcare-segments

competitive-landscape-top-5-graphite-electrode-companies-listed

targeted-protein-degradation-market

black-soldier-fly-market

automotive-coatings-market

field-programmable-gate-array-fpga-market

digital-printing-market

japan-fuel-cell-market